|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.70 EUR | +3.09% |
|
-4.12% | +11.64% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 17.51x | 2.02x | -2.54x | 3.84x | 10.32x | 11.38x | 0.58% | 68.8B | ||
| 27.36x | 4.11x | 2.09x | 5.63x | 16.53x | 20.89x | 0.58% | 55.21B | ||
| 35.27x | 7.08x | 0.69x | 11.95x | 22.64x | 26.61x | -.--% | 43.46B | ||
| -46.27x | 2.52x | 0.36x | 3.25x | 9.6x | 11.21x | 3.32% | 41.18B | ||
| -9.21x | 5.42x | -0.48x | 13.41x | -8.22x | -7.77x | -.--% | 31.65B | ||
| 31.34x | 1.61x | -1.24x | 3.56x | 11.02x | 12.92x | -.--% | 30.37B | ||
| 17.13x | 3.43x | 2.29x | 3.29x | 9.96x | 9.78x | -.--% | 23.58B | ||
| 56.27x | 5.53x | 0.3x | 6.08x | 42.2x | 39.03x | -.--% | 19.33B | ||
| 26.8x | 3.75x | 0.02x | 5.49x | 14.74x | 20.37x | -.--% | 17.16B | ||
| -35.54x | -6.21x | 0.85x | 16.63x | -50.5x | -52.95x | -.--% | 15.27B | ||
| -125.69x | 13228.81x | 2.73x | 12.92x | -114.56x | -127.57x | -.--% | 12.85B | ||
| 61.75x | 25.18x | 0.58x | 37.5x | 53.04x | 54.7x | 0.15% | 11.93B | ||
| 17.13x | - | 0.18x | 3.64x | 13.33x | 15.98x | -.--% | 11.66B | ||
| 47.81x | - | 3.76x | - | - | - | -.--% | 10.87B | ||
| 73.49x | 5.2x | -0.94x | - | - | - | - | 6.95B | ||
| 11.89x | 1.04x | 0.41x | 1.81x | 7.29x | 9.77x | 2.82% | 6.24B | ||
| 14.54x | 1.34x | -0.21x | 2.59x | 6.7x | 8.11x | 1.55% | 5.83B | ||
| 28.21x | - | 1.38x | 7.57x | 20.1x | 24x | 0.37% | 5.74B | ||
| -44.98x | - | -0.81x | - | - | - | - | 5.67B | ||
| Average | 10.78x | 886.05x | 0.50x | 8.70x | 4.01x | 4.78x | 0.55% | 22.3B | |
| Weighted average by Cap. | 11.40x | 440.04x | 0.21x | 7.57x | 7.80x | 9.17x | 0.58% |
- Stock Market
- Stocks
- ZLAB Stock
- 1ZL Stock
- Sector Zai Lab Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















